Predictive Model for Assessing the Risk of Taxane-Related Peripheral Neuropathy in Patients with Early-Stage Cancer - Quiz - MDSpire

Predictive Model for Assessing the Risk of Taxane-Related Peripheral Neuropathy in Patients with Early-Stage Cancer

  • By

  • Meghna S. Trivedi

  • Joseph M. Unger

  • N. Lynn Henry

  • Amy K. Darke

  • Daniel L. Hertz

  • Thomas H. Brannagan

  • Stephanie J. Reyes

  • Bryan P. Schneider

  • William J. Irvin

  • Amanda R. Hathaway

  • Amy C. Vander Woude

  • Vinay K. Gudena

  • Paula Cabrera-Galeana

  • Mary Orsted

  • Michael LeBlanc

  • Michael J. Fisch

  • Dawn L. Hershman

  • April 10, 2026

  • 0 min

Share

Original Source(s)

Predictive Model for Assessing the Risk of Taxane-Related Peripheral Neuropathy in Patients with Early-Stage Cancer

  • by Meghna S. Trivedi, Joseph M. Unger, N. Lynn Henry, Amy K. Darke, Daniel L. Hertz, Thomas H. Brannagan, Stephanie J. Reyes, Bryan P. Schneider, William J. Irvin, Amanda R. Hathaway, Amy C. Vander Woude, Vinay K. Gudena, Paula Cabrera-Galeana, Mary Orsted, Michael LeBlanc, Michael J. Fisch, Dawn L. Hershman

  • April 10, 2026

Related Content

Acupuncture for post-chemoradiotherapy complications in lung cancer with bone metastasis: a case report and literature review

Multiple ground-glass nodules after lobectomy for multiple primary lung cancer: a case report

Zapnometinib treatment and influenza A virus infection modulate the HLA class I ligandome in human lung adenocarcinoma cells